Pricing Log in Create free account

Nautilus Biotechnology, Inc. (NAUT) vs Q32 Bio Inc. (QTTB)

Nautilus Biotechnology, Inc. and Q32 Bio Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and Q32 Bio Inc. are of similar size ($273.9M and $263.5M). Nautilus Biotechnology, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 3.1×. Across the 10 metrics below, Q32 Bio Inc. leads on 10 and Nautilus Biotechnology, Inc. on 0.

Valuation

Metric NAUT QTTB Biotechnology median
P/E n/m 3.07 10.60
P/S n/m n/m 9.40
P/B 2.43 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m (13.63) 9.02
Earnings yield (20.76%) 32.54% (32.88%)
Free cash flow yield (19.43%) (6.84%) (23.13%)

Profitability

Metric NAUT QTTB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) 72.14% (51.96%)
Return on assets (33.49%) 37.13% (46.06%)
Return on invested capital (133.48%) 0.00% 0.00%

Growth

Metric NAUT QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 6.76%
EPS growth (last fiscal year) 16.07% 136.78% 29.88%
Revenue growth, 5-year CAGR — 100.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NAUT QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.25 20.30 4.97
Net debt to EBITDA 1.67 (2.21) 1.01

Dividend

Metric NAUT QTTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NAUT QTTB Biotechnology median
Market cap 273.85m 263.46m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack